News | October 13, 2014

New Imaging Tool May Prevent Strokes

October 13, 2014 -- A study using a new imaging tool, optical coherence tomography (OCT), offered a new look at the composition of carotid artery disease and has the potential to alter how physicians understand and treat the disease, a leading cause of stroke.

The study, conducted at Baptist Health Lexington between September 2010 and May 2012, was featured in the June 2014 issue of the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. Interventional cardiologist Michael R. Jones, M.D., served as a principal investigator of the study, which also included neurosurgeons William H. Brooks, M.D., and Christian N. Ramsey, M.D., neurointerventional radiologist Curtis A. Given II, M.D., along with physicians from Case Western Reserve University in Cleveland, Ohio and Pitangueiras Hospital in Jundiai, Brazil.

The study involved a retrospective review of 53 patients suspected of having carotid artery stenosis, a narrowing caused by the build-up of plaque. The patients – both symptomatic and asymptomatic for stroke – underwent diagnostic carotid angiography as well as OCT.

"Because OCT offers such high resolution images, we were able to identify some plaque as 'vulnerable' or 'unstable,'" explained Jones.

Physicians have suspected that unstable plaque is at risk for rupture. The body treats a rupture in a blood vessel as a wound and forms a blood clot to stop the bleeding. This clot can then dislodge from the plaque and travel to the brain causing a stroke. Less commonly, the plaque itself can break off and travel to the brain.

The study revealed that symptomatic patients had a larger percentage of unstable plaque but actually less blockage when compared to the plaque found in vessels of asymptomatic patients.

It has long been thought that opening carotid arteries severely narrowed by plaque – either with surgery or a stent – is one of the most effective ways to prevent stroke. The OCT study revealed that severity of the narrowing was not as much of a predictor of stroke as the composition of the plaque itself.

"This study, along with others sure to come, could change the way we test patients with carotid artery disease," Jones said. "It could be that they might be better served with looking at the type of plaque they have rather than by measuring the severity of their blockage."

For more information visit: www.baptisthealthlexington.com

Related Content

Medication Alone May Not Eliminate Stroke Risk in Carotid Atherosclerotic Stenosis Patients
News | Stroke | October 31, 2018
Recent statin and medication advances have led some researchers to suggest surgical treatments for carotid stenosis...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Stroke | August 28, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Breast feeding may help reduce the stroke risk in women. Katherine Fornell

Breast feeding may help reduce the stroke risk in women.

News | Stroke | August 22, 2018
Breastfeeding is not only good for babies, according to new research in the Journal of the American Heart Association....
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
July 13, 2018 – iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAP
NewYork-Presbyterian Expands Mobile Stroke Treatment Unit Fleet
News | Stroke | June 11, 2018
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the...
International Study Suggests Combination Therapy May Prevent Stroke in Certain People
News | Stroke | June 07, 2018
June 7, 2018 — Results from an international clinical trial show that combining...
The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain. A new clinical trial at The Ohio State University Wexner Medical Center is examining use of this device for stroke rehabilitation.

A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses vagus nerve stimulation to help stroke patients regain motor function. The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain. 

News | Stroke | May 09, 2018
May 9, 2018 — Stroke rehabilitation specialists at the The Ohio State University Wexner Medical Center are among the
Videos | Stroke | May 09, 2018
A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses va
Northwestern Medicine Mobile Stroke Unit Delivers Life-Saving Care 30 Minutes Sooner
News | Stroke | May 07, 2018
A new data analysis of the Northwestern Medicine Mobile Stroke Unit (MSU) found the specialized ambulance provided life...
360 Photos | Stroke | May 01, 2018
This is a 360 degree view inside the back of the Northwestern Medicine Central DuPage Hospital Mobile Stroke Unit amb
Overlay Init